help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Booth, S. L.
Right arrow Articles by Kiel, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Booth, S. L.
Right arrow Articles by Kiel, D. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHYTONADIONE
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 10 4904-4909
Copyright © 2004 by The Endocrine Society

Associations between Vitamin K Biochemical Measures and Bone Mineral Density in Men and Women

Sarah L. Booth, Kerry E. Broe, James W. Peterson, Debbie M. Cheng, Bess Dawson-Hughes, Caren M. Gundberg, L. Adrienne Cupples, Peter W. F. Wilson and Douglas P. Kiel

Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (S.L.B., J.W.P., B.D.-H.), Boston, Massachusetts 02111; the Framingham Heart Study (P.W.F.W.), Framingham, Massachusetts 01702; Beth Israel-Deaconess Hospital, Hebrew Rehabilitation Center for Aged Research and Training Institute (K.E.B., D.P.K.) and Harvard Medical School Division on Aging (D.P.K.), Harvard Medical School, Boston, Massachusetts 02131; Departments of Medicine and Preventive Medicine and Epidemiology (P.W.F.W.) and the Department of Biostatistics (D.M.C., L.A.C.), Boston University, Boston, Massachusetts 02118; and Department of Orthopedics and Rehabilitation (C.M.G.), Yale University, New Haven, Connecticut 06510

Address all correspondence and requests for reprints to: Sarah L. Booth, Ph.D., Vitamin K Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111. E-mail: sarah.booth{at}tufts.edu.

Few data exist on the association between vitamin K status and bone mineral density (BMD) in men and women of varying ages. We examined cross-sectional associations between biochemical measures of vitamin K status and BMD at the hip and spine in 741 men and 863 women (mean age, 59 yr; range, 32–86 yr) who participated in the Framingham Heart Study (1996–2000). Vitamin K status was assessed by plasma phylloquinone and percentage undercarboxylated osteocalcin (%ucOC). Among the men, low plasma phylloquinone concentrations adjusted for triglycerides and elevated serum %ucOC levels were associated with low BMD at the femoral neck (P = 0.03 and 0.009, respectively). Among postmenopausal women not using estrogen replacements, low plasma phylloquinone concentrations were associated with low spine BMD (P = 0.007), with a nonsignificant trend of an elevated serum %ucOC with low spine BMD (P = 0.08). In contrast, there were no significant associations between biochemical measures of vitamin K and BMD in either premenopausal women or postmenopausal women using estrogen replacements. Clinical trials are required to isolate any putative effects of vitamin K on rates of bone loss. The target population in these trials, particularly in regard to estrogen use, may be critical, as suggested by the findings of this study.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. L. Booth, G. Dallal, M. K. Shea, C. Gundberg, J. W. Peterson, and B. Dawson-Hughes
Effect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. K. Shea, S. L. Booth, J. M. Massaro, P. F. Jacques, R. B. D'Agostino Sr, B. Dawson-Hughes, J. M. Ordovas, C. J. O'Donnell, S. Kathiresan, J. F. Keaney Jr, et al.
Vitamin K and Vitamin D Status: Associations with Inflammatory Markers in the Framingham Offspring Study
Am. J. Epidemiol., February 1, 2008; 167(3): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
D. A. Pearson
Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants
Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. K. Azharuddin, D. St. J. O'Reilly, A. Gray, and D. Talwar
HPLC Method for Plasma Vitamin K1: Effect of Plasma Triglyceride and Acute-Phase Response on Circulating Concentrations
Clin. Chem., September 1, 2007; 53(9): 1706 - 1713.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. Cockayne, J. Adamson, S. Lanham-New, M. J. Shearer, S. Gilbody, and D. J. Torgerson
Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Arch Intern Med, June 26, 2006; 166(12): 1256 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. Tsugawa, M. Shiraki, Y. Suhara, M. Kamao, K. Tanaka, and T. Okano
Vitamin K status of healthy Japanese women: age-related vitamin K requirement for {gamma}-carboxylation of osteocalcin
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 380 - 386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society